Barely Significant
← all excerpts

The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: results of the GO-FISH trial.

Diabetes Care · 2013 · PMC3661851 · PMID 23275364

Europe PMCDOI
1
hedged sentence
0.0600
closest p · 1.2× alpha
0.0600
boldest claim

The sentences

borderline significantP = 0.06so close (0.05 < p ≤ 0.1)
In stratified analysis by use of chronic stable doses of diuretics, statins, oral hypoglycemic medications, and RAAS-inhibitor medications, interaction terms used to evaluate the effects of RAAS and n-3 PUFA supplementation use were significant for NGAL ( P = 0.01), NAG ( P < 0.01), and microalbuminuria ( P = 0.04), borderline significant for LFABP ( P = 0.06), and nonsignificant for KIM-1 ( P = 0.35) ( Table 3 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.